EC
HLF icon

Elequin Capital’s Herbalife HLF Stock Holding History

Elequin Capital’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$707 Sell
48
-120
-71% -$1.96K ﹤0.01% 560
2025
Q4 		$2.17K Buy
+168
New +$1.78K ﹤0.01% 354
2025
Q3 		– Sell
-94
Closed -$810 – 247
2025
Q2 		$810 Buy
+94
New +$698 ﹤0.01% 343
2025
Q1 		– Sell
-6
Closed -$40 – 459
2024
Q4 		$40 Sell
6
-818
-99% -$6.08K ﹤0.01% 503
2024
Q3 		$5.92K Buy
+824
New +$7.59K ﹤0.01% 283
2024
Q2 		– Sell
-761
Closed -$7.65K – 259
2024
Q1 		$7.65K Buy
761
+722
+1,851% +$7.76K ﹤0.01% 124
2023
Q4 		$595 Sell
39
-15
-28% -$207 ﹤0.01% 319
2023
Q3 		$755 Sell
54
-1,139
-95% -$17.2K ﹤0.01% 335
2023
Q2 		$15.8K Buy
+1,193
New +$16.2K 0.01% 253
2023
Q1 		– Sell
-111
Closed -$1.65K – 418
2022
Q4 		$1.65K Buy
111
+66
+147% +$1.15K ﹤0.01% 586
2022
Q3 		$1K Sell
45
-21
-32% -$520 ﹤0.01% 516
2022
Q2 		$1K Sell
66
-6
-8% -$148 ﹤0.01% 356
2022
Q1 		$2K Buy
+72
New +$2.82K ﹤0.01% 259

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Elequin Capital's HLF Position: Q1 2026 in Review

Elequin Capital reduced its Herbalife (HLF) stake by 71% in Q1 2026, selling an estimated $1.96K and leaving 48 shares worth $707. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Elequin Capital first reported a position in HLF in Q1 2022 and has held it in 13 quarters since. The position peaked at $15.8K in Q2 2023. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Elequin Capital held 48 shares of Herbalife worth $707 as of Q1 2026.
  • Elequin Capital sold 120 Herbalife shares in Q1 2026, an estimated $1.96K.
  • Herbalife made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #560 holding.
  • Elequin Capital first reported a position in Herbalife in Q1 2022 and has held it in 13 quarters since.
  • Elequin Capital's Herbalife position peaked at $15.8K in Q2 2023.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.